- Home
- UBX vs PAVM Comparison
UBX vs PAVM Comparison
Compare UBX & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- PAVM
- Stock Information
- Founded
- UBX 2009
- PAVM 2014
- Country
- UBX United States
- PAVM United States
- Employees
- UBX N/A
- PAVM N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- UBX Health Care
- PAVM Health Care
- Exchange
- UBX Nasdaq
- PAVM Nasdaq
- Market Cap
- UBX 13.9M
- PAVM 12.0M
- IPO Year
- UBX 2018
- PAVM 2016
- Fundamental
- Price
- UBX $0.78
- PAVM $0.60
- Analyst Decision
- UBX Strong Buy
- PAVM Strong Buy
- Analyst Count
- UBX 3
- PAVM 1
- Target Price
- UBX $4.67
- PAVM $19.00
- AVG Volume (30 Days)
- UBX 609.1K
- PAVM 156.8K
- Earning Date
- UBX 08-05-2025
- PAVM 08-11-2025
- Dividend Yield
- UBX N/A
- PAVM N/A
- EPS Growth
- UBX N/A
- PAVM N/A
- EPS
- UBX N/A
- PAVM 0.96
- Revenue
- UBX N/A
- PAVM $1,993,000.00
- Revenue This Year
- UBX N/A
- PAVM N/A
- Revenue Next Year
- UBX N/A
- PAVM $455.63
- P/E Ratio
- UBX N/A
- PAVM $0.63
- Revenue Growth
- UBX N/A
- PAVM N/A
- 52 Week Low
- UBX $0.36
- PAVM $0.55
- 52 Week High
- UBX $3.10
- PAVM $1.90
- Technical
- Relative Strength Index (RSI)
- UBX 48.12
- PAVM 42.29
- Support Level
- UBX $0.67
- PAVM $0.59
- Resistance Level
- UBX $0.83
- PAVM $0.64
- Average True Range (ATR)
- UBX 0.09
- PAVM 0.04
- MACD
- UBX 0.01
- PAVM -0.00
- Stochastic Oscillator
- UBX 24.67
- PAVM 24.62
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.